DOJ reports California physician sentenced in Medicare Botox billing case

Published November 4, 2026 · Coverage October 25–31, 2026, Pacific · High priority

DOJ reports that a California physician received a 15-year sentence after convictions in a Medicare Botox billing scheme. The court ordered restitution and forfeiture, with restitution collection and net recovery not established in the announcement.

What changed

DOJ announced October 30 that a federal court sentenced California physician Violetta Mailyan to 15 years in prison on October 29. DOJ reports that, following a six-day jury trial ending in May 2026, she was convicted of nine wire-fraud counts and three counts of obstruction of a criminal investigation of a health care offense. DOJ says the case involved more than $45 million billed to Medicare for Botox services that were medically unnecessary or never provided. According to the release’s account of trial evidence, thousands of billed injections were never given, were cosmetic, or involved patients whose primary-care physicians had not referred them for chronic-migraine treatment; claims representing more than $19 million purportedly concerned days when the clinic was closed. Those are billed amounts, not a finding that the same amount was paid or recovered.

DOJ reports that the court ordered $32,904,049.41 in restitution to Medicare and immediate forfeiture of more than $16,029,742 in seized property, including real and personal property, securities and bank funds. Those are distinct court-ordered amounts; the announcement does not establish the amount of restitution collected or net recovery after any allocation. DOJ also describes evidence of falsified medical records and forged beneficiary signatures submitted to investigators. This account is based on the agency’s announcement. The judgment, appeal status, trial record and actual collections or net recovery have not been independently established.

Why it matters

For providers administering high-cost injectable drugs, the reported conduct illustrates the value of reconciling documentation and billing against actual patient encounters, clinical indications, drug administration and practitioner availability.

Suggested action

Compliance and revenue-cycle owners can test a risk-based sample for services billed during office closures or provider absences and investigate discrepancies, while preserving records and escalating suspected falsification through established procedures. The case does not establish that an unmatched referral alone proves fraud or that a particular organization has violated a rule.

Sources

Botox Fraud Doctor Sentenced to 15 Years in Prison for $45M Medicare Scheme, U.S. Department of Justice; source date 2026-10-30.